Percentage of subjects with hSBA titres ≥1 : 8 and hSBA GMTs against serogroups A, C, W-135, and Y at 42 days after one dose of MenACWY-TT in toddlers (ATP immunogenicity cohort).
Vaccine
% ≥ 1 : 8 [95% CI]
GMT [95% CI]
hSBA-MenA
MenACWY-TT
338
77.2 [72.4–81.6]
19.0 [16.4–22.1]
MenACWY-TT + MMRV
348
83.9 [79.6–87.6]
33.7 [28.9–39.2]
hSBA-MenC
MenACWY-TT
341
98.5 [96.6–99.5]
196.0 [175.4–219.0]
MenACWY-TT + MMRV
346
98.0 [95.9–99.2]
209.1 [183.8–238.0]
MenC-CRM197
116
81.9 [73.7–88.4]
40.3 [29.5–55.1]
hSBA-MenW-135
MenACWY-TT
336
87.5 [83.5–90.8]
48.9 [41.2–58.0]
MenACWY-TT + MMRV
337
82.8 [78.3–86.7]
57.3 [47.0–69.9]
hSBA-MenY
MenACWY-TT
329
79.3 [74.5–83.6]
30.9 [25.8–37.1]
MenACWY-TT + MMRV
333
81.4 [76.8–85.4]
38.7 [32.2–46.7]
: numbers of subjects with available data, %: percentage of subjects with titre within the specified range, 95% CI: 95% confidence interval, GMT: Geometric Mean Titre, Results of this table were previously published [90].
